"We would invest Rs 500 crore in the four Greenfield projects coming up in the next three years," Habil Khorakiwala, chairman, Wockhardt said on Wednesday at a function to announce the accreditation it received from Joint Commission International.
The funds required would be raised via equity or debt, but the exact formula was yet to be decided, he said, adding the company had no plans to hit the bourses and all the needs would be met via internal accruals.
The 400-bed Bangalore project was expected to be operational in next six months, Khorakiwala said, adding that it would also go for obtaining JCI recognition.
Wockhardt is a Rs 1,239 crore (Rs 12.39 billion) group with 4,000 employees and a state-of-the-art research centre in India with eight manufacturing facilities in India and one located in UK.
The group has business ranging from manufacturing, formulations, bulk drugs, vaccines and medical nutrition.